Differential ChIP-seq Peak Calling — Comparative Chromatin Binding Analysis
Differential Chromatin Immunoprecipitation Sequencing Peak Calling · Also known as: differential ChIP-seq, ChIP-seq differential binding analysis, comparative peak calling, differential chromatin occupancy analysis
Differential ChIP-seq peak calling identifies genomic loci where a protein of interest — typically a transcription factor or histone mark — shows significantly altered binding or occupancy between two or more biological conditions. By combining standard ChIP-seq peak detection with count-based statistical testing, the method reveals condition-specific regulatory elements, providing a genome-wide map of dynamic chromatin interactions underlying cellular state changes.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use differential ChIP-seq peak calling when you have replicated ChIP-seq data (minimum two biological replicates per condition) for the same antibody target across two or more conditions — treated versus untreated, wild-type versus mutant, or distinct cell types — and your goal is to identify which specific loci show altered binding. It is particularly valuable for transcription factors and active histone marks where sharp, localized changes are expected. Do not use this approach when you have only one replicate per condition (replication is required for statistical testing), when comparing different antibody targets (the shared-peak assumption breaks down), or when your question concerns total binding intensity rather than locus-specific changes.
Strengths & limitations
- Provides genome-wide, locus-resolution maps of condition-specific protein-chromatin interactions.
- Leverages well-validated count-based statistical frameworks (DESeq2, edgeR) with established false-discovery rate control.
- Peak annotation directly links chromatin changes to target genes, enabling mechanistic interpretation.
- Motif enrichment in differential peaks reveals co-regulatory transcription factors without additional experiments.
- Applicable to transcription factors, activating or repressive histone marks, and chromatin remodelers.
- Requires biological replicates — at least two per condition — without which no rigorous statistical testing is possible.
- Antibody specificity is a critical and often under-reported confound; batch effects from different antibody lots can mimic differential binding.
- Consensus peakset construction requires careful threshold choices — overly lenient merging inflates false positives while overly strict merging misses genuine condition-specific peaks.
- Broad or diffuse histone marks are challenging because standard narrow-peak callers and count windows perform poorly, and alternative tools such as SICER or EPIC2 are less standardized.
- High-confidence differential analysis typically requires 20-40 million uniquely mapped reads per sample, making it resource-intensive.
Frequently asked
How many replicates do I need?
A minimum of two biological replicates per condition is required for any count-based model to estimate within-condition variance. Three replicates per condition substantially improve power and are recommended by ENCODE. With two replicates, only large fold-changes reach significance; with three or more, moderate changes are detectable at standard FDR thresholds.
Should I use DESeq2, edgeR, or DiffBind?
DiffBind is a Bioconductor wrapper that calls either DESeq2 or edgeR internally, handling ChIP-seq-specific steps such as consensus peak construction and count extraction. For most users, DiffBind with DESeq2 normalization is the most convenient and reproducible option. Using DESeq2 or edgeR directly is appropriate when you need fine-grained control over normalization or model design.
Can I apply this workflow to ATAC-seq or CUT&RUN data?
Yes. The differential peak calling framework — consensus peakset, count matrix, DESeq2 or edgeR testing — applies directly to ATAC-seq open-chromatin data and CUT&RUN or CUT&TAG targeted profiling data, with adjustments to peak caller settings and fragment size filtering appropriate to each assay.
What if peak numbers differ greatly between my conditions?
Large differences in total peak number can indicate a global binding shift, such as a drug activating thousands of enhancers. In this case TMM normalization — which assumes most peaks are unchanged — is invalid. Use spike-in chromatin normalization (ChIP-Rx) or assess whether a global normalization assumption is biologically justified before interpreting fold-changes.
How do I handle a study with more than two conditions?
DESeq2 and edgeR support multi-factor designs and pairwise contrasts among three or more conditions, analogous to multi-group differential expression analysis. Specify the experimental design matrix to account for any blocking factors (batch, donor), and test each pairwise comparison of interest with appropriate FDR correction across all contrasts.
Sources
- Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., Ali, S., Chin, S. F., Palmieri, C., Caldas, C., & Carroll, J. S. (2012). Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature, 481(7381), 389-393. link ↗
- Stark, R., & Brown, G. (2011). DiffBind: differential binding analysis of ChIP-Seq peak data. Bioconductor Package, Cancer Research UK Cambridge Research Institute. link ↗
How to cite this page
ScholarGate. (2026, June 3). Differential Chromatin Immunoprecipitation Sequencing Peak Calling. ScholarGate. https://scholargate.app/en/bioinformatics/differential-chip-seq-peak-calling
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- ATAC-seq AnalysisGenetics↔ compare
- ChIP-seq Peak CallingBioinformatics↔ compare
- Epigenome-wide association studyBioinformatics↔ compare
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare
- Variant CallingBioinformatics↔ compare